293 related articles for article (PubMed ID: 38231069)
1. Current Status of Hedgehog Signaling Inhibitors.
Wang X; Wang T; Song X; Gao J; Xu G; Ma Y; Song G
Curr Top Med Chem; 2024; 24(3):243-258. PubMed ID: 38231069
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Hedgehog Antagonists for Cancer Therapy.
Khatra H; Bose C; Sinha S
Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
[TBL] [Abstract][Full Text] [Related]
3. Hedgehog Signaling: From Basic Biology to Cancer Therapy.
Wu F; Zhang Y; Sun B; McMahon AP; Wang Y
Cell Chem Biol; 2017 Mar; 24(3):252-280. PubMed ID: 28286127
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog signaling pathway inhibitors: an updated patent review (2015-present).
Quaglio D; Infante P; Di Marcotullio L; Botta B; Mori M
Expert Opin Ther Pat; 2020 Apr; 30(4):235-250. PubMed ID: 32070165
[No Abstract] [Full Text] [Related]
5. Hedgehog signaling pathway and cancer therapeutics: progress to date.
Ruch JM; Kim EJ
Drugs; 2013 May; 73(7):613-23. PubMed ID: 23605693
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype.
Infante P; Alfonsi R; Ingallina C; Quaglio D; Ghirga F; D'Acquarica I; Bernardi F; Di Magno L; Canettieri G; Screpanti I; Gulino A; Botta B; Mori M; Di Marcotullio L
Cell Death Dis; 2016 Sep; 7(9):e2376. PubMed ID: 27899820
[TBL] [Abstract][Full Text] [Related]
7. Development of anticancer agents targeting the Hedgehog signaling.
Zhang X; Tian Y; Yang Y; Hao J
Cell Mol Life Sci; 2017 Aug; 74(15):2773-2782. PubMed ID: 28314894
[TBL] [Abstract][Full Text] [Related]
8. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics.
Peukert S; Miller-Moslin K
ChemMedChem; 2010 Apr; 5(4):500-12. PubMed ID: 20229564
[TBL] [Abstract][Full Text] [Related]
11. Strategies to target the Hedgehog signaling pathway for cancer therapy.
Xin M; Ji X; De La Cruz LK; Thareja S; Wang B
Med Res Rev; 2018 May; 38(3):870-913. PubMed ID: 29315702
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
Scales SJ; de Sauvage FJ
Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog pathway and smoothened inhibitors in cancer therapies.
Chahal KK; Parle M; Abagyan R
Anticancer Drugs; 2018 Jun; 29(5):387-401. PubMed ID: 29537987
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog inhibition as an anti-cancer strategy.
Raju GP; Pham D
Vitam Horm; 2012; 88():507-22. PubMed ID: 22391319
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.
Maschinot CA; Pace JR; Hadden MK
Curr Med Chem; 2015; 22(35):4033-57. PubMed ID: 26310919
[TBL] [Abstract][Full Text] [Related]
16. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation.
Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H
Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656
[TBL] [Abstract][Full Text] [Related]
17. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract][Full Text] [Related]
18. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
19. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies.
Banerjee U; Hadden MK
Expert Opin Drug Discov; 2014 Jul; 9(7):751-71. PubMed ID: 24850423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
